| Structure of the dengue virus envelope protein after membrane fusion Y Modis, S Ogata, D Clements, SC Harrison Nature 427 (6972), 313-319, 2004 | 1494 | 2004 |
| A ligand-binding pocket in the dengue virus envelope glycoprotein Y Modis, S Ogata, D Clements, SC Harrison Proceedings of the National Academy of Sciences 100 (12), 6986-6991, 2003 | 1285 | 2003 |
| Conformational changes of the flavivirus E glycoprotein Y Zhang, W Zhang, S Ogata, D Clements, JH Strauss, TS Baker, RJ Kuhn, ... Structure 12 (9), 1607-1618, 2004 | 568 | 2004 |
| Variable surface epitopes in the crystal structure of dengue virus type 3 envelope glycoprotein Y Modis, S Ogata, D Clements, SC Harrison Journal of virology 79 (2), 1223-1231, 2005 | 538 | 2005 |
| Development of a recombinant tetravalent dengue virus vaccine: immunogenicity and efficacy studies in mice and monkeys DE Clements, BAG Coller, MM Lieberman, S Ogata, G Wang, KE Harada, ... Vaccine 28 (15), 2705-2715, 2010 | 235 | 2010 |
| An evaluation of dengue type-2 inactivated, recombinant subunit, and live-attenuated vaccine candidates in the rhesus macaque model JR Putnak, BA Coller, G Voss, DW Vaughn, D Clements, I Peters, ... Vaccine 23 (35), 4442-4452, 2005 | 219 | 2005 |
| The development of recombinant subunit envelope-based vaccines to protect against dengue virus induced disease BAG Coller, DE Clements, AJ Bett, SL Sagar, JH Ter Meulen Vaccine 29 (42), 7267-7275, 2011 | 180 | 2011 |
| Dengue vaccines: progress and challenges BAG Coller, DE Clements Current opinion in immunology 23 (3), 391-398, 2011 | 160 | 2011 |
| Use of recombinant envelope proteins for serological diagnosis of dengue virus infection in an immunochromatographic assay AJ Cuzzubbo, TP Endy, A Nisalak, S Kalayanarooj, DW Vaughn, ... Clinical Diagnostic Laboratory Immunology 8 (6), 1150-1155, 2001 | 154 | 2001 |
| Preparation and immunogenic properties of a recombinant West Nile subunit vaccine MM Lieberman, DE Clements, S Ogata, G Wang, G Corpuz, T Wong, ... Vaccine 25 (3), 414-423, 2007 | 105 | 2007 |
| Immunogenicity and protective efficacy of a recombinant subunit West Nile virus vaccine in rhesus monkeys MM Lieberman, VR Nerurkar, H Luo, B Cropp, R Carrion Jr, ... Clinical and Vaccine Immunology 16 (9), 1332-1337, 2009 | 90 | 2009 |
| Preclinical development of a dengue tetravalent recombinant subunit vaccine: Immunogenicity and protective efficacy in nonhuman primates D Govindarajan, S Meschino, L Guan, DE Clements, JH ter Meulen, ... Vaccine 33 (33), 4105-4116, 2015 | 71 | 2015 |
| Preclinical and clinical development of a dengue recombinant subunit vaccine SB Manoff, SL George, AJ Bett, ML Yelmene, G Dhanasekaran, ... Vaccine 33 (50), 7126-7134, 2015 | 67 | 2015 |
| Subunit immonogenic composition against dengue infection J Ivy, E Nakano, D Clements US Patent 6,165,477, 2000 | 65 | 2000 |
| Multiple copies of a DNA sequence from Pseudomonas syringae pathovar phaseolicola abolish thermoregulation of phaseolotoxin production KB Rowley, DE Clements, M Mandel, T Humphreys, SS Patil Molecular microbiology 8 (3), 625-635, 1993 | 61 | 1993 |
| Efficacy and durability of a recombinant subunit West Nile vaccine candidate in protecting hamsters from West Nile encephalitis DM Watts, RB Tesh, M Siirin, AT da Rosa, PC Newman, DE Clements, ... Vaccine 25 (15), 2913-2918, 2007 | 54 | 2007 |
| Methods of preparing carboxy-terminally truncated recombinant flavivirus envelope glycoproteins employing drosophila melanogaster expression systems J Ivy, E Nakano, D Clements US Patent 6,136,561, 2000 | 50 | 2000 |
| Recombinant proteins of Zaire ebolavirus induce potent humoral and cellular immune responses and protect against live virus infection in mice AT Lehrer, TAS Wong, MM Lieberman, T Humphreys, DE Clements, ... Vaccine 36 (22), 3090-3100, 2018 | 40 | 2018 |
| A recombinant subunit based Zika virus vaccine is efficacious in non-human primates LO Medina, A To, MM Lieberman, TAS Wong, M Namekar, E Nakano, ... Frontiers in immunology 9, 2464, 2018 | 35 | 2018 |
| A novel synthetic TLR-4 agonist adjuvant increases the protective response to a clinical-stage West Nile virus vaccine antigen in multiple formulations N Van Hoeven, SW Joshi, GI Nana, A Bosco-Lauth, C Fox, RA Bowen, ... PLoS One 11 (2), e0149610, 2016 | 30 | 2016 |
